Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial.

Authors	Thomas E Stinchcombe
Journal	Journal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 41 Issue 6 Pg. 1159-1160 (02 20 2023) ISSN: 1527-7755 [Electronic] United States
PMID	36791472 (Publication Type: Editorial)
Chemical References	Gefitinib High-Q-Bond Methacrylates Antineoplastic Agents
Topics	Humans Carcinoma, Non-Small-Cell Lung (drug therapy) Gefitinib (therapeutic use) Lung Neoplasms (drug therapy) Methacrylates (therapeutic use) Antineoplastic Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!